dalteparin has been researched along with Ischemic Attack, Transient in 9 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Ischemic Attack, Transient: Brief reversible episodes of focal, nonconvulsive ischemic dysfunction of the brain having a duration of less than 24 hours, and usually less than one hour, caused by transient thrombotic or embolic blood vessel occlusion or stenosis. Events may be classified by arterial distribution, temporal pattern, or etiology (e.g., embolic vs. thrombotic). (From Adams et al., Principles of Neurology, 6th ed, pp814-6)
| Excerpt | Relevance | Reference |
|---|---|---|
| " High-dose atorvastatin reduces recurrent stroke in patients with recent stroke, but probably slightly increases central nervous system hemorrhage (SPARCL)." | 4.84 | What's new in stroke? The top 10 studies of 2006-2008. Part II. ( Hart, RG, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sengupta, N | 1 |
| Feuerstein, JD | 1 |
| Patwardhan, VR | 1 |
| Tapper, EB | 1 |
| Ketwaroo, GA | 1 |
| Thaker, AM | 1 |
| Leffler, DA | 1 |
| Karapurkar, AP | 1 |
| Singh, R | 1 |
| Teelala, SM | 1 |
| Lalla, R | 1 |
| Hart, RG | 1 |
| Ahmed, I | 1 |
| Gertner, E | 1 |
| Nelson, WB | 1 |
| House, CM | 1 |
| Dahiya, R | 1 |
| Anderson, CP | 1 |
| Benditt, DG | 1 |
| Zhu, DW | 1 |
| Gardner, MJ | 1 |
| Flik, KR | 1 |
| Dreese, JC | 1 |
| Athanasian, EA | 1 |
| Lyden, JP | 1 |
| Sherman, DG | 1 |
| Albers, GW | 1 |
| Bladin, C | 1 |
| Fieschi, C | 1 |
| Gabbai, AA | 1 |
| Kase, CS | 1 |
| O'Riordan, W | 1 |
| Pineo, GF | 1 |
| Melero, MJ | 1 |
| Bergroth, B | 1 |
| Contardo, DM | 1 |
| Mazzei, MM | 1 |
| Martins, HS | 1 |
| Scalabrini-Neto, A | 1 |
| Velasco, IT | 1 |
| Sakurai-Yamashita, Y | 1 |
| Kinugawa, H | 1 |
| Niwa, M | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| An Open-Label, Randomized, Parallel-Group, Multi-Center Study to Evaluate the Efficacy and Safety of Enoxaparin Versus Unfractionated Heparin in the Prevention of Venous Thromboembolism in Patients Following Acute Ischemic Stroke[NCT00077805] | Phase 4 | 0 participants | Interventional | 2003-08-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 review available for dalteparin and Ischemic Attack, Transient
| Article | Year |
|---|---|
What's new in stroke? The top 10 studies of 2006-2008. Part II.
Topics: Anticoagulants; Atorvastatin; Drug Therapy, Combination; Enoxaparin; Evidence-Based Medicine; Fibrin | 2008 |
1 trial available for dalteparin and Ischemic Attack, Transient
| Article | Year |
|---|---|
The efficacy and safety of enoxaparin versus unfractionated heparin for the prevention of venous thromboembolism after acute ischaemic stroke (PREVAIL Study): an open-label randomised comparison.
Topics: Aged; Anticoagulants; Enoxaparin; Female; Heparin, Low-Molecular-Weight; Humans; Ischemic Attack, Tr | 2007 |
7 other studies available for dalteparin and Ischemic Attack, Transient
| Article | Year |
|---|---|
The risks of thromboembolism vs. recurrent gastrointestinal bleeding after interruption of systemic anticoagulation in hospitalized inpatients with gastrointestinal bleeding: a prospective study.
Topics: Aged; Aged, 80 and over; Anticoagulants; Benzimidazoles; beta-Alanine; Cohort Studies; Dabigatran; E | 2015 |
Free-floating thrombus in a stenotic supraclinoid left internal carotid artery.
Topics: Aged; Anticoagulants; Aphasia; Carotid Artery, Internal; Carotid Stenosis; Enoxaparin; Female; Human | 2016 |
Continuing warfarin therapy is superior to interrupting warfarin with or without bridging anticoagulation therapy in patients undergoing pacemaker and defibrillator implantation.
Topics: Aged; Anticoagulants; Atrial Fibrillation; Cardiac Pacing, Artificial; Chronic Disease; Confidence I | 2010 |
Atraumatic compartment syndrome of the dorsal compartment of the upper arm.
Topics: Acute Disease; Aged; Arm; Aspirin; Compartment Syndromes; Diagnosis, Differential; Enoxaparin; Femal | 2006 |
Prevention of venous thromboembolism after acute ischaemic stroke.
Topics: Dose-Response Relationship, Drug; Drug Administration Schedule; Enoxaparin; Heparin, Low-Molecular-W | 2007 |
Prevention of venous thromboembolism after acute ischaemic stroke.
Topics: Anticoagulants; Cost-Benefit Analysis; Enoxaparin; Heparin; Humans; Ischemic Attack, Transient; Pres | 2007 |
Neuroprotective effect of pentosan polysulphate on ischemia-related neuronal death of the hippocampus.
Topics: Animals; Anticoagulants; Blood-Brain Barrier; Carotid Artery, Common; Cell Death; Dalteparin; Hippoc | 2006 |